Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744601 · ClinicalTrials.gov registry record
Impulsivity, Neural Deficits and Cocaine Addiction
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 90
- Enrollment target
NCT00744601: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00744601 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00744601 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to assess neurocognitive and associated neural regions/circuitry disruptions relevant to impulsive relapse in cocaine-addicted subjects, and the relationship of the cognitive and neural mechanisms of impulsivity/decision-making to relapse style.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-09 |
What the finished NCT00744601 record still lists
NCT00744601 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00744601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00744601 about?
NCT00744601 is a clinical study titled "Impulsivity, Neural Deficits and Cocaine Addiction". The purpose of this study is to assess neurocognitive and associated neural regions/circuitry disruptions relevant to impulsive relapse in cocaine-addicted subjects, and the relationship of the cognitive and neural mechanisms of impulsivity/decision-making to relapse style.
What is the current status of trial NCT00744601?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2007-04. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT00744601?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia